α-Linolenic Acid Reduces Growth of Both Triple Negative and Luminal Breast Cancer Cells in High and Low Estrogen Environments

REFERENCES

• Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, et al.: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Washington, DC: International Agency for Research on Cancer, 2013. Retrieved from http://globocan.iarc.fr.
   Google Scholar
• Berquin IM, Edwards IJ, and Chen YQ: Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett 269, 363–377, 2008.
   PubMed Web of Science ®Google Scholar
• Greenlee H, Kwan ML, Ergas IJ, Sherman KJ, Krathwohl SE, et al.: Complementary and alternative therapy use before and after breast cancer diagnosis: The pathways study. Breast Cancer Res Treat 117, 653–665, 2009.
   PubMed Web of Science ®Google Scholar
• Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, et al.: Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA 295, 2492–2502, 2006.
   PubMed Web of Science ®Google Scholar
• Blanckaert V, Ulmann L, Mimouni V, Antol J, Brancquart L, et al.: Docosahexaenoic acid intake decreases proliferation, increases apoptosis and decreases the invasive potential of the human breast carcinoma cell line MDA-MB-231. Int J Oncol 36, 737, 2010.
   PubMed Web of Science ®Google Scholar
• Corsetto PA, Montorfano G, Zava S, Jovenitti IE, Cremona A, et al.: Effects of n-3 PUFAs on breast cancer cells through their incorporation in plasma membrane. Lipids Health Dis 10, 73, 2011.
   PubMed Web of Science ®Google Scholar
• Kim J, Park HD, Park E, Chon J, and Park YK: Growth‐inhibitory and proapoptotic effects of alpha‐linolenic acid on estrogen‐positive breast cancer cells. Ann N Y Acad Sci 1171, 190–195, 2009.
   PubMed Web of Science ®Google Scholar
• Truan JS, Chen J, and Thompson LU: Flaxseed oil reduces the growth of human breast tumors (MCF‐7) at high levels of circulating estrogen. Mol Nutr Food Res 54, 1414–1421, 2010.
   PubMed Web of Science ®Google Scholar
• Chajès V, Sattler W, Stranzl A, and Kostner GM: Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: Relationship to peroxides and vitamin-E. Breast Cancer Res Treat 34, 199–212, 1995.
   PubMed Web of Science ®Google Scholar
• Mason JK, Chen J, and Thompson LU: Flaxseed oil–trastuzumab interaction in breast cancer. Food Chem Toxicol 48, 2223–2226, 2010.
   PubMed Web of Science ®Google Scholar
• Chamras H, Ardashian A, Heber D, and Glaspy JA: Fatty acid modulation of MCF-7 human breast cancer cell proliferation, apoptosis and differentiation. J Nutr Biochem 13, 711–716, 2002.
   PubMed Web of Science ®Google Scholar
• Chajès V, Hultén K, Van Kappel A, Winkvist A, Kaaks R, et al.: Fatty-acid composition in serum phospholipids and risk of breast cancer: An incident case-control study in Sweden. Int J Cancer 83, 585–590, 1999.
   PubMed Web of Science ®Google Scholar
• Chajès V, Thiébaut A, Rotival M, Gauthier E, Maillard V, et al.: Association between serum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC study. Am J Epidemiol 167, 1312–1320, 2008.
   PubMed Web of Science ®Google Scholar
• Pala V, Krogh V, Muti P, Chajès V, Riboli E, et al.: Erythrocyte membrane fatty acids and subsequent breast cancer: A prospective Italian study. J Natl Cancer Inst 93, 1088–1095, 2001.
   PubMed Web of Science ®Google Scholar
• Saadatian-Elahi M, Toniolo P, Ferrari P, Goudable J, Akhmedkhanov A, et al.: Serum fatty acids and risk of breast cancer in a nested case-control study of the New York University Women's health study. Cancer Epidemiol Biomarkers Prev 11, 1353–1360, 2002.
   PubMed Web of Science ®Google Scholar
• Shannon J, King IB, Moshofsky R, Lampe JW, Gao DL, et al.: Erythrocyte fatty acids and breast cancer risk: A case-control study in Shanghai, China. Am J Clin Nutr 85, 1090–1097, 2007.
   PubMed Web of Science ®Google Scholar
• Takata Y, King IB, Neuhouser ML, Schaffer S, Barnett M, et al.: Association of serum phospholipid fatty acids with breast cancer risk among postmenopausal cigarette smokers. Cancer Causes Control 20, 497–504, 2009.
   PubMed Web of Science ®Google Scholar
• Vatten LJ, Bjerve KS, Andersen A, and Jellum E: Polyunsaturated fatty acids in serum phospholipids and risk of breast cancer: A case-control study from the Janus Serum Bank in Norway. Eur J Cancer 29, 532–538, 1993.
   Web of Science ®Google Scholar
• Wirfält E, Mattisson I, Gullberg B, Johansson U, Olsson H, et al.: Postmenopausal breast cancer is associated with high intakes of ω6 fatty acids (Sweden). Cancer Causes Control 13, 883–893, 2002.
   PubMed Web of Science ®Google Scholar
• Gago-Dominguez M, Yuan J, Sun C, Lee H, and Yu M: Opposing effects of dietary n-3 and n-6 fatty acids on mammary carcinogenesis: The Singapore Chinese health study. Br J Cancer 89, 1686–1692, 2003.
   PubMed Web of Science ®Google Scholar
• Park S, Kolonel LN, Henderson BE, and Wilkens LR: Dietary fat and breast cancer in postmenopausal women according to ethnicity and hormone receptor status: The multiethnic cohort study. Cancer Prev Res 5, 216–228, 2012.
   PubMed Web of Science ®Google Scholar
• Thiébaut AC, Chajès V, Gerber M, Boutron‐Ruault M, Joulin V, et al.: Dietary intakes of n-6 and n-3 polyunsaturated fatty acids and the risk of breast cancer. Int J Cancer 124, 924–931, 2009.
   PubMed Web of Science ®Google Scholar
• Wakai K, Tamakoshi K, Fukui M, Suzuki S, Lin Y, et al.: Dietary intakes of fat and fatty acids and risk of breast cancer: A prospective study in Japan. Cancer Sci 96, 590–599, 2005.
   PubMed Web of Science ®Google Scholar
• MacLean CH, Newberry SJ, Mojica WA, Khanna P, Issa AM, et al.: Effects of omega-3 fatty acids on cancer risk. JAMA 295, 403–415, 2006.
   PubMed Web of Science ®Google Scholar
• Zheng J, Hu X, Zhao Y, Yang J, and Li D: Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: Meta-analysis of data from 21 independent prospective cohort studies. BMJ 346, f3706, 2013.
   PubMed Web of Science ®Google Scholar
• Boucher BA, Cotterchio M, Curca IA, Kreiger N, et al.: Intake of phytoestrogen foods and supplements among women recently diagnosed with breast cancer in Ontario, Canada. Nutr Cancer 64, 695–703, 2012.
   PubMed Web of Science ®Google Scholar
• Boon HS, Olatunde F, and Zick SM: Trends in complementary/alternative medicine use by breast cancer survivors: Comparing survey data from 1998 and 2005. BMC Womens Health 7, 2007.
   Google Scholar
• Rausch SM, Winegardner F, Kruk KM, Phatak V, Wahner-Roedler DL, et al.: Complementary and alternative medicine: Use and disclosure in radiation oncology community practice. Support Care Cancer 19, 521–529, 2011.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Agriculture, Agricultural Research Service: Nutrient Intakes from Food: Mean Amounts Consumed per Individual, by Gender and Age, What We Eat in America, NHANES 2009–2010. Washington, DC: U.S. Department of Agriculture, Agricultural Research Service, 2012. Retrieved from www.ars.usda.gov/ba/bhnrc/fsrg
   Google Scholar
• Voorrips LE, Brants HA, Kardinaal AF, Hiddink GJ, van den Brandt PA, et al.: Intake of conjugated linoleic acid, fat, and other fatty acids in relation to postmenopausal breast cancer: The Netherlands cohort study on diet and cancer. Am J Clin Nutr 76, 873–882, 2002.
   PubMed Web of Science ®Google Scholar
• Chen J, Saggar JK, Corey P, and Thompson LU: Flaxseed and pure secoisolariciresinol diglucoside, but not flaxseed hull, reduce human breast tumor growth (MCF-7) in athymic mice. J Nutr 139, 2061–2066, 2009.
   PubMed Web of Science ®Google Scholar
• Saggar JK, Chen J, Corey P, and Thompson LU: Dietary flaxseed lignan or oil combined with tamoxifen treatment affects MCF‐7 tumor growth through estrogen receptor‐and growth factor‐signaling pathways. Mol Nutr Food Res 54, 415–425, 2010.
   PubMed Web of Science ®Google Scholar
• Saggar JK, Chen J, Corey P, and Thompson LU: The effect of secoisolariciresinol diglucoside and flaxseed oil, alone and in combination, on MCF-7 tumor growth and signaling pathways. Nutr Cancer 62, 533–542, 2010.
   PubMed Web of Science ®Google Scholar
• Francis A A, Deniset JF, Austria JA, LaValleé RK, Maddaford GG et al.: Effects of dietary flaxseed on atherosclerotic plaque regression. Am J Physiol-Heart C 304, H1743–H1751, 2013.
   PubMed Web of Science ®Google Scholar
• Mason JK, Kharotia S, Wiggins AKA, Kitson AP, Chen J, et al.: 17β-estradiol increases liver and serum docosahexaenoic acid in mice fed varying levels of α-linolenic acid. Lipids 49, 745–756, 2014.
   PubMed Web of Science ®Google Scholar
• Austria J, Richard M, Chahine M, Edel A, Malcolmson L, et al.: Bioavailability of alpha-linolenic acid in subjects after ingestion of three different forms of flaxseed. J Am Coll Nutr 27, 214–221, 2008.
   PubMed Web of Science ®Google Scholar
• Patenaude A, Rodriguez-Leyva D, Edel A, Dibrov E, Dupasquier CMC, et al.: Bioavailability of α-linolenic acid from flaxseed diets as a function of the age of the subject. EurJ Clin Nutr 63, 1123–1129, 2009.
   PubMed Web of Science ®Google Scholar
• Horia E, and Watkins BA: Comparison of stearidonic acid and α-linolenic acid on PGE2 production and COX-2 protein levels in MDA-MB-231 breast cancer cell cultures. J Nutr Biochem 16, 184–192, 2005.
   PubMed Web of Science ®Google Scholar
• Menendez JA, Vázquez-Martín A, Ropero S, Colomer R, Lupu R, et al.: HER2 (erbB-2)-targeted effects of the ϖ-3 polyunsaturated fatty acid α-linolenic acid (ALA; 18: 3n-3) in breast cancer cells: The ≪fat features≫ of the ≪Mediterranean diet≫ as an ≪anti-HER2 cocktail≫. Clin Transl Oncol 8, 812–820, 2006.
   PubMedGoogle Scholar
• Schley PD, Brindley DN, and Field CJ: (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells. J Nutr 137, 548–553, 2007.
   PubMed Web of Science ®Google Scholar
• Ewaschuk JB, Newell M, and Field CJ: Docosahexanoic acid improves chemotherapy efficacy by inducing CD95 translocation to lipid rafts in ER- breast cancer cells. Lipids 47, 1019–1030, 2012.
   PubMed Web of Science ®Google Scholar
• Yu H, Ewaschuk J, Newell M, Weselake R, and Field C: Inhibitory effects of n-3 and n-6 fatty acid pathway intermediates on the growth of MDA-MB-231 breast cancer cells. Appl Physiol Nutr Metab 36, 492, 2011.
   Google Scholar
• Bligh EG and Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37, 911–917, 1959.
   PubMedGoogle Scholar
• Larsson SC, Kumlin M, Ingelman-Sundberg M, and Wolk A: Dietary long-chain n-3 fatty acids for the prevention of cancer: A review of potential mechanisms. Am J Clin Nutr 79, 935–945, 2004.
   PubMed Web of Science ®Google Scholar
• Menendez JA and Lupu R: Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7, 763–777, 2007.
   PubMed Web of Science ®Google Scholar
• Sawyer MB and Field CJ: Possible mechanisms of n-3 PUFA anti-tumor action. In: Dietary Omega-3 Polyunsaturated Fatty Acids and Cancer, Calviello G and Serini S (eds.). Dordrecht, NLD: Springer, 2010, pp. 3–39.
   Google Scholar
• Staubach S and Hanisch F: Lipid rafts: Signaling and sorting platforms of cells and their roles in cancer. Expert Rev Proteomics 8, 263–277, 2011.
   PubMed Web of Science ®Google Scholar
• Corsetto PA, Cremona A, Montorfano G, Jovenitti IE, Orsini F, et al.: Chemical–physical changes in cell membrane microdomains of breast cancer cells after omega-3 PUFA incorporation. Cell Biochem Biophys 64, 45–59, 2012.
   PubMed Web of Science ®Google Scholar
• Anderson BM and Ma D: Are all n-3 polyunsaturated fatty acids created equal. Lipids Health Dis 8, 1–20, 2009.
   PubMed Web of Science ®Google Scholar
• Bernstein L, Ross R, and Henderson B: Relationship of hormone use to cancer risk. JNCI Monographs 12, 137–147, 1992.
   Google Scholar
• Clemons M and Goss P: Estrogen and the risk of breast cancer. N Engl J Med 344, 276–285, 2001.
   PubMed Web of Science ®Google Scholar
• Falany JL, Macrina N, and Falany CN: Regulation of MCF-7 breast cancer cell growth by β-estradiol sulfation. Breast Cancer Res Treat 74, 167–176, 2002.
   PubMed Web of Science ®Google Scholar
• Love-Schimenti CD, Gibson DFC, Ratnam AV, and Bikle DD: Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells. Cancer Research 56, 2789–2794, 1996.
   PubMed Web of Science ®Google Scholar
• Sakla MS, Shenouda NS, Ansell PJ, MacDonald RS, and Lubahn DB: Genistein affects HER2 protein concentration, activation, and promoter regulation in BT-474 human breast cancer cells. Endocr 32, 69–78, 2007.
   Web of Science ®Google Scholar
• Wiggins AKA, Mason JK, and Thompson LU.: Growth and gene expression differ over time in alpha-linolenic acid treated breast cancer cells. Exp Cell Res 333, 147–154, 2015.
   Google Scholar
• Arpino G, Gutierrez C, Weiss H, Rimawi M, et al.: Treatment of human epidermal growth factor receptor 2-overexpression breast cancer xenografts with multiagent HER-targeted therapy. J Natl Cancer Inst 99, 694–705, 2007.
   PubMed Web of Science ®Google Scholar
• Tran H, Bae S, Song B, Lee B, Bae Y, et al.: Pomegranate (punica granatum) seed linolenic acid isomers: Concentration-dependent modulation of estrogen receptor activity. Endocr Res 35, 1–16, 2010.
   PubMed Web of Science ®Google Scholar
• Tanmahasamut P, Liu J, Hendry LB, and Sidell N: Conjugated linoleic acid blocks estrogen signaling in human breast cancer cells. J Nutr 134, 674–680, 2004.
   PubMed Web of Science ®Google Scholar
• Lu I, Hasio A, Hu M, Yang F, and Su H: Docosahexaenoic acid induces proteasome-dependent degradation of estrogen receptor α and inhibits the downstream signaling target in MCF-7 breast cancer cells. J Nutr Biochem 21, 512–517, 2010.
   PubMed Web of Science ®Google Scholar
• Zhang G, Gurtu V, Kain SR, and Yan G: Early detection of apoptosis using a fluorescent conjugate of annexin V. Biotechniques 23, 525–531, 1997.
   PubMed Web of Science ®Google Scholar
• Miller E: Apoptosis measurement by annexin V staining. In: Cancer Cell Culture: Methods and Protocols, Langdon SP (ed.). Totowa, NJ: Humana Press, 2003, pp. 505–531.
   Google Scholar
• Wang D and DuBois RN: Eicosanoids and cancer. Nat Rev Cancer 10, 181–193, 2010.
   PubMed Web of Science ®Google Scholar
• Mason JK, Wiggins AKA, and Thompson LU: Plant and marine sources of omega-3 polyunsaturated fatty acids, inflammation, and cancer prevention. In: Inflammation, Oxidative Stress, and Cancer, Kong T (ed.). Boca Raton, FL., Taylor & Francis Group, 2013, pp. 281–298.
   Google Scholar
• Harnack K, Andersen G, and Somoza V: Quantitation of alpha-linolenic acid elongation to eicosapentaenoic and docosahexaenoic acid as affected by the ratio of n6/n3 fatty acids. Nutr Metab 6, 1–11, 2009.
   Google Scholar
• Sczaniecka AK, Brasky TM, Lampe JW, Patterson RE, and White E: Dietary intake of specific fatty acids and breast cancer risk among postmenopausal women in the VITAL cohort. Nutr Cancer 64, 1131–1142, 2012.
   PubMed Web of Science ®Google Scholar
• Bernard-Gallon DJ, Vissac-Sabatier C, Antoine-Vincent D, Rio PG, Maurizis J, et al.: Differential effects of n-3 and n-6 polyunsaturated fatty acids on BRCA1 and BRCA2 gene expression in breast cell lines. Br J Nutr 87, 281–289, 2002.
   PubMed Web of Science ®Google Scholar
• Jump DB: Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci 41, 41–78, 2004.
   PubMed Web of Science ®Google Scholar
• Song HJ, Sneddon AA, Heys SD, and Wahle KWJ: Regulation of fatty acid synthase (FAS) and apoptosis in estrogen-receptor positive and negative breast cancer cells by conjugated linoleic acids. Prostaglandins Leukot Essent Fatty Acids 87, 197–203, 2012.
   PubMed Web of Science ®Google Scholar
• Ghosh-Choudhury T, Mandal CC, Woodruff K, St Clair P, Fernandes G, et al.: Fish oil targets PTEN to regulate NFκB for downregulation of anti-apoptotic genes in breast tumor growth. Breast Cancer Res Treat 118, 213–228, 2009.
   PubMed Web of Science ®Google Scholar
• Mandal CC, Ghosh-Choudhury T, Dey N, Choudhury GG, and Ghosh-Choudhury N: miR-21 is targeted by omega-3 polyunsaturated fatty acid to regulate breast tumor CSF-1 expression. Carcinogenesis 33, 1897–1908, 2012.
   PubMed Web of Science ®Google Scholar